Compare Edwards Lifesciences Corporation Common Stock (EW) vs Kohl's Corporation (KSS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs Kohl's Corporation — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.24 (market cap $48.56B), while Kohl's Corporation trades at $20.2 (market cap $2.28B). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 21.3× Kohl's Corporation's market cap, and Kohl's Corporation pays a 2.49% dividend while Edwards Lifesciences Corporation Common Stock pays none. Which is the better fit depends on your goals.
| EW | KSS | |
|---|---|---|
Market Cap | $48.56B | $2.28B |
Volume | 6,520,488 | 4,960,280 |
Sector | Health | Consumer Cyclical |
52-Week High | $95.18 | $24.71 |
52-Week Low | $72.65 | $11.72 |
Enterprise Value | $45.01B | $7.88B |
Typical Hold Time | — | 48 Days |
Dividend Yield | — | 2.49% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Kohl's (KSS) trades at $20.12, up 2.5% today, with a bullish technical signal from moving averages but overbought RSI readings. The stock shows attractive valuation metrics with P/E of 8.64 and P/S of 0.15, though revenue has declined from $19.4B in 2022 to $16.2B in 2025. Recent Q2 2026 earnings beat expectations with EPS of $1.28 versus $0.583 expected, and the company raised full-year guidance amid merchandising improvements.
KSS presents a value opportunity with deep discount valuations, but faces headwinds from 18 consecutive quarters of declining sales. Analyst consensus is mixed with 30% buy ratings and a $15.50 price target below current levels. The turnaround story depends on stabilizing sales and executing holiday season performance, with competitive pressures and consumer spending constraints as key risks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About Kohl's Corporation
Kohl's operates 1,165 department stores in 49 states that sell moderately priced private-label and national brand clothing, shoes, accessories, cosmetics, and home furnishings. Most of these stores are in strip centers. Kohl's also operates a large digital sales business. Women's apparel is Kohl's largest category, having generated 27% of its 2021 sales. The retailer, headquartered in Menomonee Falls, Wisconsin, opened its first department store in 1962.
Read more on KSS →
